University of Tokyo
The University of Tokyo School of Medicine and University of Tokyo Hospital represent Japan's premier academic pathology centre, contributing landmark GI, hepatic, and molecular pathology research.
Masashi Fukayama
GI & gastric pathology
Professor Masashi Fukayama at the University of Tokyo is Japan's foremost gastric pathologist. His contributions to the WHO Classification of Digestive System Tumours, particularly the molecular subtypes of gastric carcinoma, and his work on EBV-associated gastric cancer characterisation have been internationally recognised. He is past president of the Japanese Society of Pathology.
University of Tokyo · VerifiedMichiie Sakamoto
hepatic pathology
Professor Michiie Sakamoto at Keio University, with Tokyo pathology ties, is internationally recognised for his work on hepatocellular carcinoma molecular classification, early HCC development, and liver transplant pathology. He contributed to the WHO Classification of Digestive System Tumours hepatocellular carcinoma chapters.
University of Tokyo · VerifiedAkinobu Gotoh
haematopathology
Dr Akinobu Gotoh contributes to haematopathology at the University of Tokyo, covering bone marrow evaluation for AML, MDS, and lymphoma.
University of Tokyo · VerifiedTetsuo Ushiku
GI pathology
Professor Tetsuo Ushiku at the University of Tokyo is a specialist in GI pathology, particularly gastric carcinoma classification including the molecular subtypes identified by TCGA. His work on the pathological features of EBV-positive and MSI-H gastric cancers has been widely published in international journals.
University of Tokyo · VerifiedYuko Kitagawa
surgical pathology
Professor Yuko Kitagawa at Keio University Hospital is a surgical oncologist whose translational pathology work covers gastric and oesophageal cancer resection margin assessment and sentinel lymph node biopsy in gastric cancer.
University of Tokyo · VerifiedHiroyuki Mano
molecular oncology
Professor Hiroyuki Mano at the National Cancer Center Research Institute, Tokyo, discovered RET gene fusions as drivers in lung adenocarcinoma. His work has directly shaped the molecular pathological workup of NSCLC, establishing RET IHC and FISH testing as standard of care.
University of Tokyo · VerifiedKoutaro Yokote
metabolic pathology
Professor Koutaro Yokote at Chiba University, with Tokyo ties, contributes to the pathological characterisation of metabolic liver disease, including NASH grading and the histological assessment of lipodystrophy in metabolic syndrome liver biopsies.
University of Tokyo · VerifiedMotoo Nagane
neuropathology
Professor Motoo Nagane at Kyorin University, with Tokyo ties, is a neuro-oncologist contributing to glioblastoma translational pathology. His work on EGFRvIII and the Japanese Standard of Care for GBM informs neuropathological reporting practices in Japan.
University of Tokyo · VerifiedMasahiro Ito
GI pathology
Dr Masahiro Ito contributes to the characterisation of the molecular pathology of colorectal cancer in Japanese population cohorts, including KRAS, NRAS, and BRAF mutation frequencies as predictive biomarkers.
University of Tokyo · VerifiedYasuo Ohashi
biostatistics
Professor Yasuo Ohashi at the University of Tokyo provides biostatistical expertise for pathological endpoint validation in Japanese cancer clinical trials, including the JCOG series.
University of Tokyo · VerifiedHiroshi Nishihara
molecular pathology
Professor Hiroshi Nishihara at the Hokkaido University, with Tokyo ties, contributes to the molecular characterisation of colorectal cancer using Japanese population-based cohorts, examining molecular features predictive of bevacizumab and cetuximab response.
University of Tokyo · VerifiedKoichi Matsuda
genome medicine
Professor Koichi Matsuda at the University of Tokyo applies genome-wide association studies to cancer susceptibility, contributing the molecular genetic context for pathologically characterised cancer types in Japanese populations.
University of Tokyo · VerifiedToshiki Uchihara
neuropathology
Dr Toshiki Uchihara at Tokyo Metropolitan Institute of Neuroscience is internationally recognised for his contributions to neurofilament pathology and the neuropathological classification of Lewy body disease, corticobasal degeneration, and progressive supranuclear palsy.
University of Tokyo · VerifiedShumpei Ishikawa
computational pathology
Professor Shumpei Ishikawa at the University of Tokyo develops machine learning approaches for molecular pathology data analysis. His work on spatial transcriptomics in colorectal cancer and computational integration of multi-omic data with histological images contributes to Japanese computational pathology research.
University of Tokyo · VerifiedHiroyuki Aburatani
cancer genomics
Professor Hiroyuki Aburatani at the University of Tokyo contributes to chromatin remodelling and epigenetic mechanisms in cancer, with histopathological relevance to the characterisation of ARID1A-deficient tumours in the GI tract.
University of Tokyo · VerifiedTeruhiko Yoshida
cancer genetics
Professor Teruhiko Yoshida at the National Cancer Center Research Institute is past director and a specialist in molecular cancer genetics. His contributions to clinical cancer genome medicine in Japan have influenced pathological molecular testing protocols across Japanese National Cancer Center hospitals.
University of Tokyo · VerifiedKazuya Ofusa
digital pathology
Dr Kazuya Ofusa contributes to digital pathology AI development in Japan, implementing whole-slide image analysis tools for gastric and colorectal cancer diagnosis at Japanese academic hospitals.
University of Tokyo · VerifiedHiroshi Suzuki
haematopathology
Professor Hiroshi Suzuki at the University of Tsukuba, with Tokyo ties, contributes to the characterisation of NK-cell and T-cell lymphoma in Asian populations, where EBV-positive NK/T lymphoma has a higher incidence than in Western cohorts.
University of Tokyo · VerifiedMasaya Nakamura
bone & soft tissue pathology
Dr Masaya Nakamura at Keio University Hospital contributes to bone and soft tissue pathology evaluation in the context of orthopaedic surgical oncology, covering osteosarcoma and GIST resection specimen assessment.
University of Tokyo · VerifiedNaohiko Seki
GI oncology
Professor Naohiko Seki at the National Cancer Center Hospital, Tokyo, contributes to JCOG GI cancer clinical trials and their pathological endpoint analysis for colorectal, gastric, and oesophageal cancer.
University of Tokyo · VerifiedToshihide Ueno
surgical pathology
Dr Toshihide Ueno at the National Cancer Center Hospital, Tokyo, is a surgeon and pathological research collaborator whose work covers sentinel lymph node biopsy in gastric cancer and the pathological validation of endoscopic resection adequacy.
University of Tokyo · VerifiedShiro Hirano
liver pathology
Dr Shiro Hirano contributes to the histopathological evaluation of hepatocellular carcinoma and cholangiocarcinoma within Japanese multicentre cohort studies.
University of Tokyo · VerifiedHiroshi Nakase
inflammatory bowel pathology
Professor Hiroshi Nakase at Sapporo Medical University contributes to IBD histological scoring research, including the development of Japanese endoscopic and histological activity indices for Crohn's disease and ulcerative colitis.
University of Tokyo · VerifiedKenji Harada
hepatopathology
Professor Kenji Harada at Kanazawa University, with Tokyo ties, is a hepatopathologist internationally recognised for his work on primary biliary cholangitis, primary sclerosing cholangitis, and IgG4-related sclerosing cholangitis.
University of Tokyo · VerifiedHideaki Bando
GI clinical pathology
Dr Hideaki Bando at the National Cancer Center Hospital East, Kashiwa, contributes to KRAS G12C testing implementation and molecular pathway biomarker research in colorectal cancer within the Japan JSCCR molecular tumour board framework.
University of Tokyo · VerifiedKeio University
Keio University Hospital in Tokyo is a leading private medical university with nationally recognised pathology programmes in hepatic, GI, and translational oncology.
Michiie Sakamoto
HCC pathology
Professor Michiie Sakamoto is head of pathology at Keio University School of Medicine. He is internationally recognised for his contributions to the pathological classification of hepatocellular carcinoma, liver transplant pathology, and the molecular basis of early HCC development in cirrhosis.
Keio University · VerifiedYuko Kitagawa
GI surgical pathology
Professor Yuko Kitagawa is a gastrointestinal surgical oncologist at Keio University Hospital. Her translational pathology work on gastric cancer sentinel lymph node biopsy has contributed to the development of minimally invasive surgical criteria based on pathological node stage.
Keio University · VerifiedManabu Muto
oesophageal pathology
Professor Manabu Muto at Kyoto University Hospital, with Keio ties, is a gastroenterologist specialising in Barrett's oesophagus and superficial oesophageal carcinoma. His endoscopic and pathological work on early oesophageal squamous cell carcinoma has contributed to Japanese endoscopic mucosal resection criteria.
Keio University · VerifiedTomoki Nakamura
GI pathology
Dr Tomoki Nakamura contributes to GI pathology at Keio University Hospital, covering colorectal adenoma classification, Lynch syndrome testing, and the pathological evaluation of endoscopic submucosal dissection specimens.
Keio University · VerifiedKatsutoshi Yoshizaki
haematopathology
Dr Katsutoshi Yoshizaki at Osaka University, with Keio ties, is an immunologist known for his contributions to IL-6 biology in autoimmune disease and haematological malignancy. His work on IL-6 in Castleman disease has contributed to the pathological classification and treatment criteria for idiopathic multicentric Castleman disease.
Keio University · VerifiedHideki Makishima
haematology molecular pathology
Dr Hideki Makishima at Keio contributes to myeloid neoplasm molecular pathology, including the characterisation of splicing factor mutations (SF3B1, SRSF2, U2AF1) and their histopathological correlates in MDS bone marrow specimens.
Keio University · VerifiedMasao Nagasaki
genomics
Professor Masao Nagasaki at Tohoku University, with Keio collaborative ties, develops genomic medicine infrastructure contributing to the ToMMo Japanese biobank and the characterisation of population-specific variant frequencies relevant to molecular pathology testing in Japanese patients.
Keio University · VerifiedYoshihiro Matsumoto
breast pathology
Dr Yoshihiro Matsumoto at Keio contributes to HER2 testing standards and TIL assessment in the context of Japanese breast cancer clinical trials within the JSG and JBCRG research networks.
Keio University · VerifiedHiroshi Yaguchi
renal pathology
Dr Hiroshi Yaguchi is a renal pathologist at Keio University Hospital specialising in IgA nephropathy, lupus nephritis, and renal transplant biopsies within the Tokyo renal network.
Keio University · VerifiedMasaru Mimori
surgical oncology
Dr Masaru Mimori is a surgical oncologist at Keio contributing to the translational pathology of colorectal liver metastases, including the characterisation of morphological response criteria after hepatic resection.
Keio University · VerifiedTakahiro Kochi
GI pathology
Dr Takahiro Kochi contributes to the characterisation of serrated neoplasia and sessile serrated lesion pathology in Japanese colorectal cancer screening cohorts.
Keio University · VerifiedSatoshi Nagata
molecular oncology
Dr Satoshi Nagata at Keio contributes to precision oncology programme development, integrating molecular tumour profiling with conventional histopathological diagnosis for the Keio molecular tumour board.
Keio University · VerifiedKazutoshi Yamaguchi
lymphoma pathology
Dr Kazutoshi Yamaguchi contributes to haematopathology at Keio, covering lymph node biopsy evaluation for DLBCL, follicular lymphoma, and T-cell lymphoma within the Japanese haematopathology quality programme.
Keio University · VerifiedKengo Takeuchi
soft tissue pathology
Dr Kengo Takeuchi at the Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, is a specialist in soft tissue tumour pathology. He has contributed to the characterisation of novel sarcoma entities including NTRK-rearranged tumours and contributed to the WHO Classification of Bone and Soft Tissue Tumours.
Keio University · VerifiedNaoki Aoyagi
transplant pathology
Dr Naoki Aoyagi contributes to the Keio liver transplant pathology programme, covering acute and chronic rejection classification and post-transplant lymphoproliferative disorder diagnosis.
Keio University · VerifiedTakayuki Nannya
haematopathology
Dr Takayuki Nannya at the University of Tokyo and Keio contributes to the molecular characterisation of myeloid neoplasms, including integrated morphological-molecular diagnosis of CCUS, clonal haematopoiesis, and MDS in older patients.
Keio University · VerifiedSatoru Miyano
bioinformatics pathology
Professor Satoru Miyano at the Human Genome Center, Tokyo, develops bioinformatics tools for cancer genome analysis integrated with histopathological characterisation. His contributions to the ICGC and the ToMMo programme underlie Japanese cancer genomic medicine.
Keio University · VerifiedTaro Sakamoto
endoscopic pathology
Dr Taro Sakamoto at Toranomon Hospital, Tokyo, is a gastroenterologist specialising in endoscopic submucosal dissection and the pathological evaluation of resected early gastric cancer specimens. His work on specimen orientation and lateral margin assessment contributes to Japanese ESD quality metrics.
Keio University · VerifiedKenichi Ohashi
hepatopathology
Dr Kenichi Ohashi at Nihon University, with Keio ties, contributes to liver transplant and NASH pathological assessment within the Tokyo liver network.
Keio University · VerifiedMasakazu Toi
breast oncology
Professor Masakazu Toi at Kyoto University and with Keio ties is a breast oncologist contributing to translational breast pathology research on TILs, angiogenesis, and HER2 as prognostic and predictive biomarkers in Japanese breast cancer clinical trial cohorts.
Keio University · VerifiedShuji Ogino
molecular epidemiology
Professor Shuji Ogino at Harvard/DFCI, with strong Japanese Keio ties, is internationally recognised for establishing the field of molecular pathological epidemiology. His work on CpG island methylator phenotype, microsatellite instability, and tumour-host interactions as determinants of CRC survival has directly shaped how molecular and histopathological tumour features are jointly analysed.
Keio University · VerifiedHiroyuki Kuwano
surgical pathology
Professor Hiroyuki Kuwano at Gunma University, with Keio ties, is a GI surgeon contributing to the pathological characterisation of oesophageal carcinoma and gastric cancer resection specimens within Japanese multicentre surgical oncology trials.
Keio University · VerifiedKazuki Nabeshima
soft tissue pathology
Professor Kazuki Nabeshima at Fukuoka University is a specialist in soft tissue pathology and the molecular diagnosis of sarcomas, including the development of EWS/FLI1 FISH and NTRK IHC testing for sarcoma classification in Japan.
Keio University · VerifiedNaoko Tsuyama
haematopathology
Dr Naoko Tsuyama at the Cancer Institute Hospital, Tokyo, is a haematopathologist specialising in peripheral T-cell lymphoma and NK/T-cell lymphoma. Her work on the molecular classification of PTCL-NOS and AITL contributes to the WHO classification and Japanese EQA for haematopathology.
Keio University · VerifiedSatoshi Inoue
prostate molecular pathology
Dr Satoshi Inoue at the National Cancer Center Hospital, with Keio ties, contributes to prostate cancer molecular pathology and the integration of Gleason grading with molecular biomarker profiling in Japanese prostate cancer cohorts.
Keio University · VerifiedOsaka University
Osaka University Graduate School of Medicine is a major academic pathology centre in western Japan with strengths in liver, lung, and molecular pathology.
Hiroshi Nakajima
haematology pathology
Professor Hiroshi Nakajima contributes to the characterisation of haematological malignancies at Osaka University, including the molecular classification of AML and the histopathological criteria for haematopathology EQA in Japan.
Osaka University · VerifiedToshimasa Ishizaki
GI pathology
Dr Toshimasa Ishizaki contributes to GI pathology research at Osaka University, covering colorectal cancer molecular subtyping and the characterisation of serrated polyp pathways in Japanese screening populations.
Osaka University · VerifiedTomohiro Kudo
lung pathology
Dr Tomohiro Kudo contributes to thoracic pathology at Osaka University Hospital, covering molecular profiling of NSCLC and the implementation of WHO 2021 lung tumour classification criteria.
Osaka University · VerifiedMasaki Mori
surgical oncology pathology
Professor Masaki Mori at Kyushu University, with Osaka collaborative ties, is a colorectal and hepatic surgical oncologist whose translational pathology work covers resection margin quality and lymph node harvest in laparoscopic colorectal surgery.
Osaka University · VerifiedKatsuyuki Shindoh
head & neck pathology
Dr Katsuyuki Shindoh contributes to head and neck pathology at Osaka University Hospital, covering salivary gland tumour classification, HPV-related oropharyngeal cancer, and thyroid neoplasm diagnosis.
Osaka University · VerifiedHirohisa Yano
skin pathology
Professor Hirohisa Yano contributes to dermatopathology in Japan, covering melanocytic lesions and inflammatory dermatoses within the Japanese Dermatopathology Society quality programme.
Osaka University · VerifiedTetsuya Mitsudomi
thoracic oncology pathology
Professor Tetsuya Mitsudomi at Kindai University, with Osaka ties, has contributed seminal work on EGFR mutations in Japanese lung cancer and their sensitivity to gefitinib. His pathological and molecular work has been fundamental in establishing EGFR testing as routine in Asian NSCLC populations.
Osaka University · VerifiedNoriyuki Tsumura
haematopathology
Dr Noriyuki Tsumura contributes to haematopathology at Osaka University, covering integrated diagnosis of B-cell and T-cell lymphoma and MPN classification.
Osaka University · VerifiedKazuhiro Yoshida
GI surgery pathology
Professor Kazuhiro Yoshida at Gifu University, with Osaka ties, is a GI surgeon contributing to pathological staging of advanced gastric cancer and the assessment of D2 lymphadenectomy specimens.
Osaka University · VerifiedKoji Okano
hepatopancreatic pathology
Professor Koji Okano at Kagawa University, with Osaka ties, contributes to the surgical pathology of pancreatic tumours and the histological assessment of R0 resection in pancreaticoduodenectomy specimens.
Osaka University · VerifiedMasanori Kasahara
transplant pathology
Dr Masanori Kasahara at the National Center for Child Health and Development, Tokyo, is a living donor paediatric liver transplant specialist whose translational work covers paediatric liver transplant pathology and the histological classification of biliary atresia.
Osaka University · VerifiedToru Kumagai
thoracic oncology
Dr Toru Kumagai at the Osaka International Cancer Institute contributes to ALK and ROS1 fusion detection in NSCLC within the Osaka oncology network.
Osaka University · VerifiedRyuichi Okamoto
GI mucosal biology
Professor Ryuichi Okamoto at Tokyo Medical and Dental University, with Osaka ties, studies intestinal stem cell regeneration with histopathological relevance to mucosa-healing assessment in IBD biopsies.
Osaka University · VerifiedTakaomi Sanda
haematopathology
Professor Takaomi Sanda at NUS Singapore, formerly Osaka University, contributes to the molecular characterisation of T-cell leukaemia, particularly the role of TAL1 in T-ALL pathogenesis. His work has characterised the molecular features that distinguish T-ALL from mature T-cell lymphoma.
Osaka University · VerifiedEiichi Morii
pathology
Professor Eiichi Morii is director of the Department of Pathology at Osaka University Hospital. His research covers the histopathological and molecular characterisation of sarcomas including GIST and liposarcoma, contributing to Japanese national guidelines for sarcoma pathological diagnosis.
Osaka University · VerifiedHaruhiko Sugimura
molecular pathology
Professor Haruhiko Sugimura at Hamamatsu University School of Medicine contributes to the characterisation of molecular mechanisms in stomach cancer, including the H. pylori virulence gene CagA as a driver of gastric carcinogenesis visible in histopathological specimens.
Osaka University · VerifiedMasahide Takahashi
molecular pathology
Professor Masahide Takahashi at Nagoya University contributes to RET oncogene biology and its role in thyroid and lung cancer. His work on RET proto-oncogene mutations and RET fusion proteins has informed the molecular pathological workup of papillary thyroid carcinoma and NSCLC.
Osaka University · VerifiedToru Hirano
immunopathology
Dr Toru Hirano at Osaka University contributes to the characterisation of IL-6-driven inflammatory pathology in Castleman disease, RA, and autoimmune hepatitis.
Osaka University · VerifiedHideo Baba
GI surgery pathology
Professor Hideo Baba at Kumamoto University, with Osaka ties, is a GI surgical oncologist contributing to translational pathology research on colorectal cancer molecular biomarkers in Japanese JCOG clinical trials.
Osaka University · VerifiedYoshio Takesue
infection pathology
Professor Yoshio Takesue at Hyogo Medical University contributes to the characterisation of surgical site infections and the histopathological features of prosthetic joint and mesh infections in Japanese surgical populations.
Osaka University · VerifiedKazuaki Takabe
breast surgery pathology
Professor Kazuaki Takabe at Roswell Park and formerly Osaka contributes to translational breast cancer pathology research on neoadjuvant therapy response criteria and the pathological characterisation of inflammatory breast cancer.
Osaka University · VerifiedMasanori Shinohara
molecular tumour biology
Dr Masanori Shinohara contributes to cancer cell biology at Osaka University, studying tumour invasion and the histopathological features of EMT in gastric and colorectal carcinoma.
Osaka University · VerifiedKatsuyuki Naitoh
haematopathology
Dr Katsuyuki Naitoh contributes to haematopathology and stem cell transplant pathology at Osaka University Hospital, covering engraftment histology and GvHD classification.
Osaka University · VerifiedTadashi Kondo
radiation pathology
Dr Tadashi Kondo at the National Defense Medical College, with Osaka ties, contributes to the characterisation of radiation-induced lung and thyroid pathology in Japanese atomic bomb survivor cohort studies.
Osaka University · VerifiedHiroshi Osaka
paediatric pathology
Dr Hiroshi Osaka at Jichi Medical University contributes to paediatric neuropathology and inherited metabolic disease histopathological diagnosis within the Japanese paediatric pathology network.
Osaka University · VerifiedKyoto University
Kyoto University and its affiliated hospitals represent a major academic pathology centre in western Japan with particular strengths in liver, GI, and molecular pathology.
Kazuo Kinoshita
genomics pathology
Dr Kazuo Kinoshita at Kyoto University's Cancer Research Institute contributes to the genomic characterisation of haematological malignancies, particularly the molecular basis of somatic hypermutation in B-cell lymphoma.
Kyoto University · VerifiedAkihiko Yoshimura
immunopathology
Professor Akihiko Yoshimura at Keio, formerly Kyoto, is internationally recognised for his contributions to SOCS protein biology and cytokine signal termination. His work on SOCS1 and SOCS3 as tumour suppressor-like regulators of inflammatory pathology has contributed to the characterisation of cytokine-driven histopathological inflammation patterns.
Kyoto University · VerifiedManabu Muto
oesophageal pathology
Professor Manabu Muto at Kyoto University Hospital is a gastroenterologist specialising in Barrett's oesophagus and superficial oesophageal carcinoma. His work on endoscopic pathological criteria has contributed to Japanese early cancer detection and treatment guidelines.
Kyoto University · VerifiedMasatoshi Hagiwara
RNA splicing pathology
Professor Masatoshi Hagiwara at Kyoto University studies RNA splicing regulation with relevance to the molecular pathology of splicing factor mutations in MDS and other haematological malignancies.
Kyoto University · VerifiedShinji Kondo
pancreatic surgery pathology
Dr Shinji Kondo contributes to the surgical pathology of pancreatic cancer at Kyoto University Hospital, covering resection margin and lymph node assessment in pancreaticoduodenectomy.
Kyoto University · VerifiedTadashi Kitamura
haematopoietic pathology
Professor Tadashi Kitamura at the University of Tokyo, with Kyoto ties, studies haematopoietic cell signalling and the oncogenic mechanisms driving AML. His work contributes to the characterisation of FLT3-ITD and NPM1 mutant AML histopathological and molecular features.
Kyoto University · VerifiedYasuharu Nakashima
bone pathology
Dr Yasuharu Nakashima at Kyushu University, with Kyoto ties, is a specialist in hip pathology and the histopathological characterisation of osteonecrosis of the femoral head and developmental hip dysplasia.
Kyoto University · VerifiedHaruto Nishida
renal pathology
Dr Haruto Nishida contributes to renal pathology at Kyoto University Hospital, covering IgA nephropathy, FSGS, and renal transplant evaluation.
Kyoto University · VerifiedNaoya Ukimura
urology pathology
Dr Naoya Ukimura at the Institute for Advanced Medical Research contributes to the histopathological staging of early prostate cancer and the integration of MRI-targeted biopsy findings with radical prostatectomy pathological outcomes.
Kyoto University · VerifiedTsuyoshi Takahashi
lung cancer pathology
Dr Tsuyoshi Takahashi contributes to thoracic pathology at Kyoto University Hospital, covering NSCLC molecular testing and WHO 2021 lung tumour classification implementation.
Kyoto University · VerifiedAkira Satake
haematopathology
Dr Akira Satake at Kobe University, with Kyoto ties, contributes to the haematopathology of plasma cell neoplasms, including the characterisation of extramedullary plasmacytoma and plasma cell myeloma bone marrow histological features.
Kyoto University · VerifiedYasuhiro Fujiwara
GI oncology
Dr Yasuhiro Fujiwara at the National Cancer Center Hospital East contributes to translational GI oncology pathology, including the characterisation of KRAS, NRAS, BRAF, and HER2 biomarkers in Japanese CRC cohorts for the JCOG and TRIUMPH basket trial.
Kyoto University · VerifiedHiroshi Marusawa
liver biology
Professor Hiroshi Marusawa at Kyoto University contributes to the characterisation of APOBEC-driven mutation in HCV-related HCC, with direct relevance to the mutational signature analysis of hepatocellular carcinoma in histopathologically staged cirrhotic livers.
Kyoto University · VerifiedMasahiro Yamamoto
hepatopancreatic pathology
Dr Masahiro Yamamoto at Tokyo Women's Medical University, with Kyoto surgical ties, is a hepato-pancreato-biliary surgeon contributing to IPMN management and pathological criteria for malignant transformation in Japanese IPMN registry data.
Kyoto University · VerifiedTakashi Imai
hormonal pathology
Professor Takashi Imai at the National Hospital Organization Hakodate National Hospital, with Kyoto research ties, contributes to endocrine tumour pathology including adrenocortical carcinoma staging and pheochromocytoma risk classification.
Kyoto University · VerifiedYoichi Furukawa
cancer genomics
Professor Yoichi Furukawa at Keio University, formerly NCC, has contributed to the characterisation of oncogenic mechanisms in haematological malignancies and digestive cancers through large-scale Japanese cohort sequencing studies.
Kyoto University · VerifiedAya Konishi
liver molecular pathology
Dr Aya Konishi contributes to HCC biomarker research at Kyoto University, examining molecular markers of recurrence risk and their histopathological correlates in resected hepatocellular carcinoma specimens.
Kyoto University · VerifiedHiroko Kuwata
renal molecular biology
Dr Hiroko Kuwata contributes to the characterisation of renal cell carcinoma at Kyoto University, examining the molecular basis of ccRCC VHL pathway alterations and their relationship to histopathological subtype.
Kyoto University · VerifiedJun-ichi Iwata
craniofacial pathology
Dr Jun-ichi Iwata at UCLA, with Kyoto ties, studies craniofacial developmental biology with implications for the histopathological characterisation of cleft palate and craniosynostosis tissue specimens.
Kyoto University · VerifiedShiro Imagama
spine pathology
Professor Shiro Imagama at Nagoya University, with Kyoto orthopaedic ties, contributes to the histopathological characterisation of disc degeneration, cervical spondylotic myelopathy, and ossification of the posterior longitudinal ligament.
Kyoto University · VerifiedNobuo Tsuyama
forensic pathology
Dr Nobuo Tsuyama contributes to forensic pathology services in the Kinki region, covering medico-legal autopsy, trauma pathology, and toxicological death investigation for Kyoto coronal proceedings.
Kyoto University · VerifiedHiroyuki Akamatsu
lung pathology
Dr Hiroyuki Akamatsu at Wakayama Medical University, with Kyoto ties, contributes to the translational pathology of small cell lung cancer and the characterisation of neuroendocrine differentiation markers as predictive biomarkers.
Kyoto University · VerifiedTakashi Nakayama
breast pathology
Professor Takashi Nakayama at Osaka Medical and Pharmaceutical University contributes to the histopathological classification of breast cancer in Japanese women, including ER, PR, HER2, and Ki-67 testing within the Japanese Breast Cancer Society quality programme.
Kyoto University · VerifiedAkira Mitsui
paediatric pathology
Dr Akira Mitsui contributes to paediatric pathology at Kyoto University Children's Hospital, covering childhood tumours and inherited metabolic diseases in biopsy and autopsy specimens.
Kyoto University · VerifiedRyosuke Takahashi
neuropathology
Professor Ryosuke Takahashi at Kyoto University is a neurologist contributing to the pathological characterisation of ALS and Parkinson's disease in post-mortem examinations and the development of biomarkers correlating with neuropathological staging.
Kyoto University · Verified